
Sign up to save your podcasts
Or


Recorded on January 15, 2021
Join Drs. Wendy Stock and Olatoyosi Odenike from The University of Chicago Medicine, in an important discussion on the progress in the treatment of acute myeloid leukemia, including important updates from the LLS Beat AML Master Trial. Drs. Stock and Odenike talk with Dr. Ken Miller about determining a treatment plan for each patient, the role genetics and epigenetics may play, what the ultimate goals of care are, including having difficult conversations with patients regarding treatment, and monitoring for measurable residual disease and maintenance therapy. Be a part of the conversation today!
By Blood Cancer United4.8
1212 ratings
Recorded on January 15, 2021
Join Drs. Wendy Stock and Olatoyosi Odenike from The University of Chicago Medicine, in an important discussion on the progress in the treatment of acute myeloid leukemia, including important updates from the LLS Beat AML Master Trial. Drs. Stock and Odenike talk with Dr. Ken Miller about determining a treatment plan for each patient, the role genetics and epigenetics may play, what the ultimate goals of care are, including having difficult conversations with patients regarding treatment, and monitoring for measurable residual disease and maintenance therapy. Be a part of the conversation today!

43,693 Listeners

316 Listeners

3,349 Listeners

56,677 Listeners

46 Listeners

1,146 Listeners

207 Listeners

187 Listeners

22 Listeners

52 Listeners

8 Listeners

20,363 Listeners

51 Listeners

44 Listeners

31 Listeners